Canine Cognitive Dysfunction
Canine Cognitive Dysfunction (CCD) is a neurodegenerative condition analogous to Alzheimer's disease in humans. It affects senior dogs, causing progressive decline in cognitive function including memory, learning, awareness, and responsiveness. Brain changes include beta-amyloid plaque deposition, oxidative damage, and neuronal loss.
Symptoms & Signs
- Disorientation in familiar environments
- Changes in social interactions
- Sleep-wake cycle disruption (nighttime waking)
- House soiling (loss of house training)
- Decreased activity and apathy
- Increased anxiety
- Staring at walls or into space
- Failure to recognize family members
Causes & Risk Factors
Age-related neurodegenerative changes including beta-amyloid accumulation, oxidative stress, mitochondrial dysfunction, and vascular changes in the brain. Risk increases with age; estimated 28% of dogs 11-12 years and 68% of dogs 15-16 years show at least one sign.
Diagnosis
Clinical diagnosis based on behavioral changes (DISHAA scoring: Disorientation, Interactions, Sleep, House soiling, Activity, Anxiety). Exclusion of other medical causes (pain, metabolic disease, sensory loss). MRI may show brain atrophy. No definitive antemortem test.
Treatment
Selegiline (Anipryl) - MAO-B inhibitor. Dietary management with antioxidants, MCTs, and omega-3s (Hill's b/d, Purina Neurocare). Environmental enrichment and mental stimulation. SAMe supplementation. Melatonin for sleep disruption. Anxiolytics if needed.
Prevention
Lifelong mental stimulation and enrichment. Regular exercise. Antioxidant-rich diet. Social interaction. Cognitive training games. Early intervention at first signs may slow progression.
Prognosis
Progressive and irreversible, but rate of decline can be slowed with multimodal management. Quality of life can be maintained for months to years with appropriate intervention. Eventually leads to severe dysfunction requiring end-of-life decisions.